On June 25, IBM rose 3.82% in pre-market trading, trading at $279.19/share, with turnover of $5.96 million. The stock continues to build on momentum from a series of positive catalysts over recent sessions.
On the news front, IBM announced the formation of an independent subsidiary named Anderon, dedicated to manufacturing silicon wafers required for quantum computing processors. The project is backed by $1 billion each from the Trump administration and IBM, totaling $2 billion in initial funding. IBM also plans to invest an additional $9 billion over the next five years to advance quantum computer R&D and scale production, while expanding into supplying key components to other quantum computing firms.
The announcement follows Trump's signing of quantum computing executive orders aimed at accelerating research and deploying a frontier-capable quantum computer by 2028. Additionally, IBM has benefited from dual analyst upgrades, with JPMorgan raising its rating to Overweight with a $291 target and Morgan Stanley lifting its target to $267, citing strong software business momentum and robust enterprise server demand.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments